Our firm represented Devalore in its acquisition by Abra.
Our firm represented Radware in the spinoff of its Cloud Native Protector (CNP) business to form a new company called […]
Our firm represented Apax Digital Fund in this financing round.
Our firm represented Pagaya Technologies in this significant financing round.
Adv. Ido Zemach, partner in the International Corporate and Securities Department, represented Brighton Park Capital in this significant financing round.
Our firm represented Itamar Medical in its Nasdaq listing and now in this significant offering.
Adv. Ashok Chandrasekhar, Head of our International Corporate and Securities Department, and Adv. Ido Zemach, partner in the department, led […]
Adv. Ido Zemach and Adv. Yoni Henner, partners in the International Corporate and Securities Department, represented Tufin in its IPO […]
Adv. Ido Zemach, partner in the International Corporate and Securities Department, represented Attunity in this significant transaction.
Adv. Ido Zemach, partner in the International Corporate and Securities Department, represented Signet Jewelers in its acquisition of R2Net.
Adv. Ido Zemach, partner in the International Corporate and Securities Department, represented Mitsubishi Tanabe Pharma Corporation in this significant transaction.
Adv. Ido Zemach, partner in the International Corporate and Securities Department, represented IDB Tourism in the transaction for the sale […]
Adv. Ashok Chandrasekhar, Head of our International Corporate and Securities Department, represented Matan Digital Printers in this transaction.
Our firm represented Google in this significant transaction.
Adv. Ido Zemach, partner in the International Corporate and Securities Department, represented Scopus in this struggle for control.
An second article by Adv. Adam Klein, Deputy Department Head of the International Corporate and Securities Department, and Adv. Ido […]
An article by Adv. Adam Klein and Adv. Ido Zemach, on Stockholder Rights Plans, or “poison pill”.
